NewKerala.com

IMA Warns Against Weight Loss Drug Misuse, Seeks Tighter Prescription Rules

The Indian Medical Association is preparing to submit a memorandum to the government calling for stricter prescription controls on GLP-1 drugs, which are intended for diabetes but are being widely misused for weight loss. IMA President Dr. Anil Kumar J. Nayak warned that taking such modern medicine without proper medical consultation is dangerous and can lead to serious side effects. This comes as the drug regulator has stepped up inspections of pharmacies and online platforms to curb unauthorized sales of these weight loss drugs. The availability of cheaper generic versions following patent expirations has increased concerns about unsupervised use and associated health risks.

Key Points: IMA Warns on Weight Loss Drug Dangers, Seeks Govt Regulation

  • IMA to give govt memo on restricting GLP-1 prescriptions
  • Drug being misused for weight loss, not just diabetes
  • Side effects include gastric issues, pancreatitis, cancer risk
  • Drug regulator intensifies monitoring of supply chain
2 min read

"Any modern medicine taken without prescription can be dangerous": IMA warns against misuse of weight loss drugs, seeks stronger regulation

Indian Medical Association warns against misuse of GLP-1 drugs for weight loss, calls for restricted prescriptions to specialists to prevent health risks.

"Any modern allopathic medicine taken without consulting a doctor is dangerous. - Dr Anil Kumar J. Nayak"

New Delhi, March 25

The Indian Medical Association has shown concern over the use of the recently introduced GLP-1 drug for the Indian markets, and soon will be giving a memorandum to the Central government regarding its restrictive use to avoid misuse. The GLP-1 has entered the Indian market at a huge discount compared to other drugs that are already available in the country.

Speaking to ANI, the Indian Medical Association President Dr Anil Kumar J. Nayak said, "We will give a memorandum to the govt for restricting prescriptions of GLP-1 drugs to certified endocrinologists/ Diabetologists or MD general medicine to curb misuse."

He further said, "The GLP-1 drug, which was introduced for diabetic patients, is being extensively used for weight loss. This is wrong because any modern allopathic medicine taken without consulting a doctor is dangerous."

He further said, "We have told at the time of introduction of GLP-1 drugs that the medicine should be taken only under the supervision of an MD physician, diabetologist and endocrinologist, as this medicine possesses side-effects like gastric trouble, nausea, vomiting, diarrhoea, pancreatitis... This can also be fatal as there is also a rare chance of thyroid cancer."

On Tuesday, the Drug Regulator stepped up vigil on the sale of Weight Loss Drugs and intensified monitoring of the supply chain of GLP-1-based weight loss drugs amid concerns over their unauthorised sale and misuse.

The inspections were conducted at 49 entities, including online pharmacies, wholesalers, retailers & wellness clinics. Notices issued for irregularities in sales and promotions. With the patent expirations for GLP-1 drugs, used for treating type 2 diabetes and obesity, major Pharma companies released cheaper generic alternatives. These alternatives are priced at a significantly lower price than the current costs.

However, concerns have emerged regarding their on-demand availability through retail pharmacies, online platforms, wholesalers, and wellness clinics. These drugs, when used without proper medical supervision, may lead to serious adverse effects and related health risks.

- ANI

Share this article:

Reader Comments

R
Rohit P
Finally! The regulator is stepping in. These online pharmacies are a menace. They sell prescription drugs like candy. I hope the government brings strict rules and hefty fines for violations. Our health system is already burdened, we don't need more patients from drug misuse.
A
Aman W
While I agree self-medication is bad, restricting it only to specialists in metros is not the full solution. What about patients in tier 2/3 cities or rural areas? There is a shortage of endocrinologists. The policy should also focus on educating all physicians.
S
Sarah B
The discount is a double-edged sword. It makes treatment affordable for genuine diabetic patients, but also makes it easily misused. The key is monitoring the supply chain, as mentioned. Wellness clinics calling it a "beauty treatment" is highly irresponsible.
V
Vikram M
Social media pressure for a "perfect" body is driving this trend. Instead of quick fixes, we need more awareness about healthy diet and exercise. These drugs have a real medical purpose and should not become a lifestyle accessory for the rich. Good move by IMA.
K
Kavya N
My aunt was prescribed this for her diabetes by a proper doctor. It helped her a lot. The problem is not the medicine, it's the people using it without prescription. The government should crack down hard on online sales. Health is not an e-commerce product.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50